<List><item><source>MED</source><extId>29259681</extId><pmcid>PMC5725926</pmcid><annotations><annotation><prefix>limumab (CAM-3001)RA</prefix><exact>NCT00771420</exact><postfix>IMTX + 0.01, 0.03, 0</postfix><tags><tag><name>NCT00771420</name><uri>http://identifiers.org/clinicaltrials/NCT00771420</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-91cbb8e5ff1fd7a3e1a055da7b547687</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>doseCompleted[121]RA</prefix><exact>NCT01050998</exact><postfix> (EARTH study)IIaMTX</postfix><tags><tag><name>NCT01050998</name><uri>http://identifiers.org/clinicaltrials/NCT01050998</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-006378fda065c478ca943a810b2605d9</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>eeksCompleted[117]RA</prefix><exact>NCT01706926</exact><postfix> (EARTH EXPLORER 1)I</postfix><tags><tag><name>NCT01706926</name><uri>http://identifiers.org/clinicaltrials/NCT01706926</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-5d8291e05ff1f3f66f0e33309f867e73</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>mpleted[122–125]RA</prefix><exact>NCT01712399</exact><postfix>IIbLong time safety </postfix><tags><tag><name>NCT01712399</name><uri>http://identifiers.org/clinicaltrials/NCT01712399</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-b7fb9cc7361910d5f1460d2afb6c6246</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>cruiting[126, 127]RA</prefix><exact>NCT01715896</exact><postfix> (EARTH EXPLORER 2)I</postfix><tags><tag><name>NCT01715896</name><uri>http://identifiers.org/clinicaltrials/NCT01715896</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-55b7e6ef67ad7aed75725f2cf2e1f3a0</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>d[128]GM-CSFMOR103RA</prefix><exact>NCT01023256</exact><postfix>Ib/IIa0.3, 1.0, and </postfix><tags><tag><name>NCT01023256</name><uri>http://identifiers.org/clinicaltrials/NCT01023256</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-b64c65609b9fd691f1d40766ff784b48</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>eeksCompleted[116]MS</prefix><exact>NCT01517282</exact><postfix>Ib0.5, 1.0, and 2.0�</postfix><tags><tag><name>NCT01517282</name><uri>http://identifiers.org/clinicaltrials/NCT01517282</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-39f2751e726e47a5366044396ffdc0a7</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>FNamilumab (MT203)RA</prefix><exact>NCT01317797</exact><postfix>Ib150 and 300 mg or</postfix><tags><tag><name>NCT01317797</name><uri>http://identifiers.org/clinicaltrials/NCT01317797</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-2238ec310b52c47adb8d0ad5bdedce1f</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>imesCompleted[129]RA</prefix><exact>NCT02393378</exact><postfix>IIMTX + namilumab or</postfix><tags><tag><name>NCT02393378</name><uri>http://identifiers.org/clinicaltrials/NCT02393378</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-a0c29282ed538ad979e879ad375165da</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>eksRecruiting[131]RA</prefix><exact>NCT02379091</exact><postfix>IIMTX + 20, 80, and </postfix><tags><tag><name>NCT02379091</name><uri>http://identifiers.org/clinicaltrials/NCT02379091</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-8a82e6d0f4bfcb0ed139fde5e54bc630</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>uiting[130]Psoriasis</prefix><exact>NCT02129777</exact><postfix>II40, 100, 160, and </postfix><tags><tag><name>NCT02129777</name><uri>http://identifiers.org/clinicaltrials/NCT02129777</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-6d002c4c8a48033afa0e0593c12f0b58</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ng[132]GM-CSFKB003RA</prefix><exact>NCT00995449</exact><postfix>II600 mg or placebo</postfix><tags><tag><name>NCT00995449</name><uri>http://identifiers.org/clinicaltrials/NCT00995449</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-6b26f0dd2ac95aee3da7c99d8222e6be</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>erminated[133]Asthma</prefix><exact>NCT01603277</exact><postfix>II400 mg or placebo</postfix><tags><tag><name>NCT01603277</name><uri>http://identifiers.org/clinicaltrials/NCT01603277</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-5d351e50abd41df95641915edf620e06</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>tedGM-CSFMORAb-022RA</prefix><exact>NCT01357759</exact><postfix>IEscalating doses of</postfix><tags><tag><name>NCT01357759</name><uri>http://identifiers.org/clinicaltrials/NCT01357759</uri></tag></tags><id>http://europepmc.org/articles/PMC5725926#europepmc-a8151b332751af3ab83cafc685d0c0f9</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>